• February 1, 2019
• 0

The National Institute for Health and Care Excellent (NICE) has approved Novartis' chimeric antigen receptor T-cell (CAR-T cell) therapy Kymriah for use in adults with diffuse large B-cell lymphoma (DLBCL)....

• January 17, 2019
• 0

Patients in the U.S. have been given digital cancer drugs for the first time in a bid to improve outcomes and adherence. The pill combines the drug capecitabine, used for grade...